. , Nature

.. .. Données-quantitatives-de-la-chirurgie,

. , Comparaison des complications entre les deux groupes

.. .. Analyse-de-suivi-des-patientes,

. .. Discussion,

.. .. Validité-interne,

.. .. Validité-externe,

. .. Mise-en-perspective,

C. .. ,

R. .. Bibliographiques,

A. .. ,

. .. Serment-d'hippocrate,

, REFERENCES BIBLIOGRAPHIQUES 1. Institut National du Cancer. Les cancers en France. édition, pp.202-210, 2015.

A. Heintz, Carcinoma of the Ovary, Int. J. Gynecol. Obstet, vol.95, pp.161-192, 2006.

, WHO classification of tumours of female reproductive organs. (International Agency for Research on Cancer, 2014.

M. A. Meyers, The Peritoneal Ligaments and Mesenterles: Pathways of Intraabdominal Spread of Disease, Radiology, vol.163, 1987.

D. Bois and A. , Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO), Cancer, vol.115, pp.1234-1244, 2009.

A. Elattar, A. Bryant, B. A. Winter-roach, M. Hatem, and R. Naik, Optimal primary surgical treatment for advanced epithelial ovarian cancer, Cochrane Database of Systematic Reviews, 2011.

C. Pomel and J. Dauplat,

, J. Chir, vol.141, pp.277-284, 2004.

J. Morère, F. Mornex, and D. Soulières, Thérapeutique du cancer, 2011.

D. S. Chi, Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm, Gynecol. Oncol, vol.114, pp.26-31, 2009.

D. Cibula, Training in Bowel and Upper Abdominal Surgery in Gynaecological Oncology, European Society of Gynecological Oncology (ESGO) Statement. Int. J. Gynecol. Cancer, vol.1, 2011.

O. Zivanovic, A. Aldini, J. W. Carlson, and D. S. Chi, Advanced cytoreductive surgery: American perspective, Gynecol. Oncol, vol.114, pp.3-9, 2009.

J. Hanprasertpong and K. Fujiwara, Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review: Splenectomy for ovarian cancer cytoreduction, Eur. J. Cancer Care (Engl.), vol.20, pp.287-293, 2011.

T. Bilgin, K. Özerkan, and H. Ozan, Splenectomy in cytoreductive surgery for advanced ovarian cancer, Arch. Gynecol. Obstet, vol.271, pp.329-331, 2005.

D. S. Chi, The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas, Gynecol. Oncol, vol.119, pp.38-42, 2010.

G. D. Aletti, Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian Cancer, Obstet. Gynecol, vol.107, pp.77-85, 2006.

S. M. Eisenkop, N. M. Spirtos, and W. M. Lin, Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer, Gynecol. Oncol, vol.100, pp.344-348, 2006.

P. M. Magtibay, P. B. Adams, M. B. Silverman, S. S. Cha, and K. C. Podratz, Splenectomy as part of cytoreductive surgery in ovarian cancer, Gynecol. Oncol, vol.102, pp.369-374, 2006.

C. Uzan, Correlation Between Macroscopic and Microscopic Diseases on Splenectomies Performed in the Surgical Management of Ovarian Cancer, Int. J. Gynecol. Cancer, vol.20, pp.965-970, 2010.

D. Querleu, É. Leblanc, P. Morice, G. Ferron, and P. Bourcier, Chirurgie des cancers gynécologiques, 2014.

N. Bisharat, H. Omari, I. Lavi, and R. Raz, Risk of Infection and Death Among Postsplenectomy Patients, J. Infect, vol.43, pp.182-186, 2001.

L. M. Boutoux, C. Uzan, S. Gouy, P. Pautier, C. Lhommé et al.,

P. Duvillard and . Morice, Splénectomie dans les tumeurs ovariennes. La Lettre du Gynécologue, vol.354, 2010.

A. Legrand, Prévention du risque infectieux postopératoire chez les patients splénectomisés, Ann. Fr. Anesth. Réanimation, vol.24, pp.807-813, 2005.

R. N. Davidson and R. A. Wall, Prevention and management of infections in patients without a spleen, Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis, vol.7, pp.657-660, 2001.

R. Buzelé, L. Barbier, A. Sauvanet, and B. Fantin, Medical complications following splenectomy, J. Visc. Surg, vol.153, pp.277-286, 2016.

R. W. Thomsen, Risk of venous thromboembolism in splenectomized patients compared with the general population and appendectomized patients: a 10-year nationwide cohort study: Letters to the Editor, J. Thromb. Haemost, vol.8, pp.1413-1416, 2010.

D. H. Lee, Splenectomy is associated with a higher risk for venous thromboembolism: A prospective cohort study, Int. J. Surg, vol.24, pp.27-32, 2015.

R. E. Bristow, R. S. Tomacruz, D. K. Armstrong, E. L. Trimble, and F. J. Montz, Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis, J. Clin. Oncol, vol.20, pp.1248-1259, 2002.

K. Kato, S. Tate, K. Nishikimi, and M. Shozu, Management of Pancreatic Fistulas After a Splenectomy as Part of Cytoreductive Surgery for Ovarian Cancer, Int. J. Gynecol. Cancer, vol.23, pp.1506-1511, 2013.

L. Xiang, Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer, J. Gynecol. Oncol, vol.27, 2016.

S. M. Kehoe, E. L. Eisenhauer, and D. S. Chi, Upper abdominal surgical procedures: Liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy

, Gynecol. Oncol, vol.111, pp.51-55, 2008.

M. Morris, Splenectomy in gynecologic oncology: indications, complications, and technique, Gynecol. Oncol, vol.43, pp.118-122, 1991.

J. Prat, . Figo-committee-on-gynecologic, and . Oncology, Staging classification for cancer of the ovary, fallopian tube, and peritoneum, Int. J. Gynecol. Obstet, vol.124, pp.1-5, 2014.

P. A. Clavien, The Clavien-Dindo Classification of Surgical Complications: FiveYear Experience, Ann. Surg, vol.250, pp.187-196, 2009.

B. L. Seagle, S. K. Butler, A. E. Strohl, W. Nieves-neira, and S. Shahabi, Chemotherapy delay after primary debulking surgery for ovarian cancer, Gynecol. Oncol, vol.144, pp.260-265, 2017.

Y. Liu, Relationship between initiation time of adjuvant chemotherapy and survival in ovarian cancer patients: a dose-response meta-analysis of cohort studies, Sci. Rep, vol.7, 2017.

M. R. Buist, Comparative Evaluation of Diagnostic Methods in Ovarian Carcinoma with Emphasis on CT and MRI, Gynecol. Oncol, vol.52, pp.191-198, 1994.

S. Taïeb, Comparative study of tumor evaluation with computerized tomography and surgery in ovarian cancer

, J. Radiol, vol.79, pp.27-32, 1998.

D. Querleu, I. Ray-coquard, and J. Classe, Les critères qualité pour la chirurgie du cancer de l'ovaire. mesure 21-3, plan cancer, pp.383-433, 2009.

C. C. Earle, Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients, JNCI J. Natl. Cancer Inst, vol.98, pp.172-180, 2006.

C. Mercado, Quality of care in advanced ovarian cancer: The importance of provider specialty, Gynecol. Oncol, vol.117, pp.18-22, 2010.

F. Vernooij, P. Heintz, E. Witteveen, and Y. Van-der-graaf, The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review, Gynecol. Oncol, vol.105, pp.801-812, 2007.

J. L. Nicklin, Splenectomy as Part of Cytoreductive Surgery for Ovarian Carcinoma

, Gynecol. Oncol, vol.58, pp.244-247, 1995.

E. J. Tanner, Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer, Gynecol. Oncol, vol.128, pp.28-33, 2013.

T. Yeung, Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis, Am. J. Physiol.-Cell Physiol, vol.309, pp.444-456, 2015.

I. Zapardiel, Splenectomy as Part of Primary Cytoreductive Surgery for Advanced Ovarian Cancer: A Retrospective Cohort Study, Int. J. Gynecol. Cancer, vol.22, pp.968-973, 2012.

C. K. Mccann, Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer, Ann. Surg. Oncol, vol.18, pp.2912-2918, 2011.

E. Kalogera, Multiple large bowel resections: Potential risk factor for anastomotic leak, Gynecol. Oncol, vol.130, pp.213-218, 2013.

S. Hendren, Surgical Complications Are Associated With Omission of Chemotherapy for Stage III Colorectal Cancer, Dis. Colon Rectum, vol.53, pp.1587-1593, 2010.

J. D. Wright, T. Doan, R. Mcbride, J. S. Jacobson, and D. L. Hershman, Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival, Br. J. Cancer, vol.98, pp.1197-1203, 2008.

I. Popescu and N. Bacalbasa, Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer-A Single Center Experience, Anticancer Research October, vol.35, pp.5649-5654, 2015.

B. Qi, Indocyanine green loaded hyaluronan-derived nanoparticles for fluorescenceenhanced surgical imaging of pancreatic cancer, Nanomedicine Nanotechnol. Biol. Med, vol.14, pp.769-780, 2018.

C. E. Hoogstins, A Novel Tumor-Specific Agent for Intraoperative Near-Infrared Fluorescence Imaging: A Translational Study in Healthy Volunteers and Patients with Ovarian Cancer, Clin. Cancer Res, vol.22, pp.2929-2938, 2016.

P. Debie, Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model, Mol. Imaging Biol, vol.20, pp.361-367, 2018.

P. Peyrat, HEPATOFLUO: A prospective monocentric study assessing the benefits of indocyanine green (ICG) fluorescence for hepatic surgery, J. Surg. Oncol, vol.117, pp.922-927, 2018.

E. Lieto, Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors, Surg. Innov, vol.25, pp.62-68, 2018.

, ANNEXES Annexe 1 classification TNM (7° édition) et stades FIGO, 2013.

, Notes : * stade IC 1 : rupture chirurgicale, stade IC 2 : rupture pré-op ou cellules tumorales à la surface de l'ovaire ou la trompe, stade IC 3 : cellules tumorales dans le liquide de lavage péritonéal

, IIIA 1 : atteinte ganglionnaire isolée, stade IIIA 2 : atteinte microscopique abdominale +/-ganglionnaire

*. , épanchement pleural avec cytologie positive, stade IV b : métastase parenchymateuse ou extra-abdominale

, Notes : exemples extraits du tableau 2 de l'article de Dindo et al « Classification of Surgical Complications, A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey, Ann. Surg, pp.205-213, 2004.